Healthy volunteers test new atopic dermatitis Drug's best form
NCT ID NCT07172321
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 31 times
Summary
This study looked at how an experimental medicine for atopic dermatitis (eczema) behaves in the body when made in different versions. Twelve healthy adults each took five different pill forms—some fast-acting, some slow-release—both on an empty stomach and after a high-fat meal. The goal was to see which version is absorbed best and how food affects it, helping researchers choose the right form for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.